Company / Operating Cash Flow per Share
NEKTAR THERAPEUTICS Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$16.84
FY2025
5-year range
-$16.84 / -$1.01
FY2021-FY2025
Trend
-1572.9%
vs FY2024
Sector context
#210 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -1573% YoY in FY2025, a notable deviation from the 9-year average annual change of -73%.
Based on SEC 10-K filings.
-16.84 in FY2025.
Declined from $-2.19 to $-16.84 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 212This company -$16.84 Sector average $5.28
▼
-419.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 1572.9% year-over-year.
- Ranks #210 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.84 | -1572.9% |
| FY2024 | -$1.01 | +54.0% |
| FY2023 | -$2.19 | -33.5% |
| FY2022 | -$1.64 | +28.5% |
| FY2021 | -$2.29 | -156.3% |
| FY2020 | $4.07 | +978.1% |
| FY2019 | -$0.46 | +36.8% |
| FY2018 | -$0.73 | -39.8% |
| FY2017 | -$0.52 | +50.0% |
| FY2016 | -$1.05 | -88.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026